Showing results (281-290 of 436) with videos related to

Sort By:
Pageof 44
International Journal of Hematology|September 21, 2023
Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 10<sup>9</sup>/LAoli Zhang, Lipeng Liu, Suyu Zong, et al.
Nature Communications|November 14, 2024
Dyna-vivo-seq unveils cellular RNA dynamics during acute kidney injury via in vivo metabolic RNA labeling-based scRNA-seqKun Yin, Yiling Xu, Ye Guo, et al.
Frontiers in Cellular Neuroscience|September 9, 2015
Myosin X regulates neuronal radial migration through interacting with N-cadherinMingming Lai, Ye Guo, Jun Ma, et al.
Frontiers in Pediatrics|December 6, 2024
The impact of SARS-CoV-2 infection on immunity reconstitution among pediatric patients after allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysisXin Wang, LiPeng Liu, Luyang Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 8, 2021
[Analysis of the Different Therapeutic Effects in 21 Ph<sup>+</sup> Acute Lymphoblastic Leukemia Children]Shu-Chun Wang, Ye Guo, Xiao-Juan Chen, et al.
Expert Review of Hematology|July 19, 2021
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphomaYuqin Song, Ye Guo, Huiqiang Huang, et al.
Clinical Chemistry and Laboratory Medicine|August 16, 2019
Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center studyLi Wang, Ye Guo, Jiang Han, et al.
BMC Cancer|May 29, 2026
Safety, pharmacokinetics, pharmacodynamics and antitumor activity of legubicin in patients with advanced solid tumors, including lung cancer: a phase 1 dose-escalation and expansion trialFengjuan Lin, Junli Xue, Qun Li, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|January 25, 2015
[Clinical features of childhood refractory cytopenia]Wen-Bin An, Pei-Hong Zhang, Yuan-Yuan Ren, et al.
Cancer Medicine|June 11, 2020
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patientsYizhen Liu, Kai Xue, Zuguang Xia, et al.
Pageof 44